Indications and uses
Anti-bacterial, reduces itchy and painful skin conditions due to eczema, athletes foot, psoriasis, jock itch, rash, skin yeast infection and more.
LMNOOP Seborrheic Dermatitis Treatment
- Manufacturer
- Shenzhen Ishan Technology Co., Ltd
- Effective date
- 2023-10-17
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-01 02:22:39
Label at a glance#
ProductLMNOOP Seborrheic Dermatitis Treatment
Active ingredientHYDROCORTISONE
Label structure11 sections
Dosage and administration
Wash and dry affected area, apply a thin layer of LMNOOP over affected area, gently massage until fully absorbed, repeat 2-3 times daily.
Storage and handling
Store at room temperature.
Label contents#
Full prescribing information#
Active ingredients
Colloidal Oatmeal--1%--Skin protectant.
Inactive Ingredients
Purify water, dictamnus dasycarpus root, stellera chamaejasme whole, sophora flavescens root, cnidium monnieri fruit, phellodendron chinense whole, bassia scoparia fruit, Menthol.
Keep out of reach of children
if swallowed, call poison control or seek medical help.
Ask a doctor
before using on children under 2 years of age.
Stop use
if condition worsens, symptoms last more than 7 days or clear up and occur again within a few days, or there is no improvement of athlete's foot or psoriasis within 4 weeks or jock itch with 2 weeks.
Uses
Anti-bacterial, reduces itchy and painful skin conditions due to eczema, athletes foot, psoriasis, jock itch, rash, skin yeast infection and more.
Other information
Store at room temperature.
Directions
Wash and dry affected area, apply a thin layer of LMNOOP over affected area, gently massage until fully absorbed, repeat 2-3 times daily.
When using this product
o not get into eyes. do not apply to wounds or damaged skin.
Warnings
For external only
Lable
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 73076-110-01 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-8e8c-d83d-e063-dadaa90ab31f | e88e597f-e2dc-54ad-e053-2995a90afe38 |
| 73076-110-02 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-8e8c-d83d-e063-dadaa90ab31f | e88e597f-e2dc-54ad-e053-2995a90afe38 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73076-110-01 | LMNOOP Seborrheic Dermatitis Treatment | 50 g in 1 PACKAGE | CREAM | 50 | 2 | |
| 73076-110-02 | LMNOOP Seborrheic Dermatitis Treatment | 100 g in 1 BOTTLE | CREAM | 100 | 2 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- LMNOOP Seborrheic Dermatitis Treatment
- BASSIA SCOPARIA FRUIT
- CNIDIUM MONNIERI FRUIT
- PHELLODENDRON CHINENSE WHOLE
- MENTHOL
- DICTAMNUS DASYCARPUS ROOT
- SOPHORA FLAVESCENS ROOT
- HYDROCORTISONE
- STELLERA CHAMAEJASME WHOLE
- MAGNOLIA SIEBOLDII ROOT
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 73076-110 | 73076-110-01, 73076-110-02 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BASSIA SCOPARIA FRUIT | 04W97Z676Y | IACT |
| CNIDIUM MONNIERI FRUIT | V1IA3S3CUS | IACT |
| PHELLODENDRON CHINENSE WHOLE | QKA3ZK8IIE | IACT |
| MENTHOL | L7T10EIP3A | IACT |
| DICTAMNUS DASYCARPUS ROOT | 6153LEN214 | IACT |
| SOPHORA FLAVESCENS ROOT | IYR6K8KQ5K | IACT |
| HYDROCORTISONE | WI4X0X7BPJ | ACTIB |
| STELLERA CHAMAEJASME WHOLE | 80N0P0DD9J | IACT |
| MAGNOLIA SIEBOLDII ROOT | F5O3IH7US3 | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 07e66f7a-4447-727c-e063-6394a90a7068 | e88e597f-e2dc-54ad-e053-2995a90afe38 | 2023-10-17 | Warnings | 07e66f7a-4447-727c-e063-6394a90a7068 e88e597f-e2dc-54ad-e053-2995a90afe38 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.